REGEN-COV antibody treatment cuts severe COVID risk at half dose, late-stage trial results show … Drug improves memory and function for those with dementia and ‘silent seizures’ … Depression relapse...
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.
Prevnar 20 can be safely administered to seniors along with a flu shot, clinical trial finds
By
Alicia Lasek
Sep 30, 2021
Study participants’ immune responses to the newly approved pneumonia vaccine and an adjuvanted flu drug were the same, whether the drugs were given together or a month apart, the drugmaker reports. And...
No unexpected pattern of adverse booster shot reactions reported by CDC app users
By
Alicia Lasek
Sep 30, 2021
Most v-safe app respondents reported mild to moderate, transient reactions, usually the day after vaccination, CDC investigators say. Sixty percent of respondents were between the ages of 50 and 74.
Clinical briefs for Thursday, Sept. 30
By
Alicia Lasek
Sep 30, 2021
Eli Lilly cuts its generic insulin price by another 40% for Medicare Part D, other beneficiaries … Federal district court judge upholds Ohio provider’s vaccine mandate … $33M awarded to determine...
Nursing home staff vaccinations get a boost thanks to New York mandate; delta ups jabs nationwide
By
Alicia Lasek
Sep 29, 2021
By midnight of its Monday deadline, New York state saw vaccination rates rise to 92% among nursing home and hospital workers, according to a new report.
Anticoagulants tied to 43 percent lower risk of COVID hospitalization
By
Alicia Lasek
Sep 29, 2021
Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...
Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
By
Alicia Lasek
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...
Clinical briefs for Wednesday, Sept. 29
By
Alicia Lasek
Sep 29, 2021
The new test case for vaccine mandates? New York home care workers may show the way … COVID cases hit longest sustained decline in 3 months: report … Physicians’ group outlines steps to help keep...
Diabetes and obesity drugs reduce COVID-19 complications, analysis shows
By
Alicia Lasek
Sep 28, 2021
Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.